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Background: The objective of this study is to establish the retroperitoneal lymph node metastasis model of
endometrial VX2 carcinoma in rabbits and observe of its metastatic features.
Methods: The VX2 cells were transplanted into the uterine muscularis mucosae of 48 rabbits by injecting
carcinoma mass suspension. According to time, the rabbits were killed after the transplantation of VX2 cells, and
they were divided into six groups, 15-, 18-, 21-, 24-, 27-, and 30-day group, and six rabbits in each group. Control
groups consisted of those receiving no treatment or an injection of saline. The specimens of transplanted endometrial
carcinoma and retroperitoneal lymph node in the rabbits were examined histopathologically after they were killed.
Results: All rabbits developed VX2 endometrial carcinoma which was confirmed with pathological examination.
Significantly increased tumor volume was observed at day 24, 27, and 30 post-injection of VX2 cells (P < 0.05). The
retroperitoneal lymph nodes were not enlarged completely in each rabbit in the 15-day group, partly enlarged in the
18- and 21-day group, and all enlarged in the 24-, 27-, and 30-day group. The histopathological examination revealed
no complete retroperitoneal lymph node metastasis in the 15- and 18-day group, partial metastasis in the 21-day
group, and complete metastasis in the 24-, 27-, and 30-day group.
Conclusions: The model was established successfully by injecting carcinoma mass suspension, and various
retroperitoneal lymph node metastasis model of endometrial VX2 carcinoma can be established rapidly in a month
after the transplantation.
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Endometrial cancer (EC) is one of the most common
malignancies of the female reproductive system [1].
Whereas patients with early-stage EC have a good prog-
nosis, those with advanced EC usually develop retroperi-
toneal lymph node (RLN) metastasis with a 5-year
survival rate ranging from 30% to 40% [2-4]. Because
RLN is next to large blood vessels in the abdominal* Correspondence: zhangyn@sysucc.org.cn
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unless otherwise stated.cavity, once RLN metastasizes and involves the blood
vessels, it increases the difficulty of surgical resection.
Radiotherapy treatment is poor if lymph node size is too
large, while intravenous chemotherapy drug concentra-
tion reaching low also affects prognosis. How to treat
RLN metastasis is a hot spot in current research. Due to
the limitation of tissue and blood drawn, it is not suit-
able for research in the human body; at present, a great
deal of studies about RLN metastasis is conducted on
animals. The VX2 cell line is composed of squamous cell
carcinoma cells derived from Shope virus-induced papil-
loma in rabbits. Their high survival rates make them a
suitable candidate for in vivo inoculation. This experi-
ment is mainly to establish the retroperitoneal lymphis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Tumor volumes over time after injection with VX2
tumor cells. The size of tumors in the experimental group was
determined at the indicated time points.
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Methods
Animals
A total of 49 female New Zealand white rabbits weighing
2 to 2.5 kg were purchased from the Huadong Xinhua
Experimental Animal Center in Guangzhou (License No:
0098816). One rabbit was used as the source of VX2
tumor cells while the remaining animals were used to
establish the in vivo model. The animals were individu-
ally housed, allowed free access to standard laboratory
food and water, and subjected to a daily 12-h light-and-
dark cycle. The animal protocol used in this study was
approved by the Center’s Animal Welfare Committee.
VX2 cells
Blocks of VX2 cells, which were kindly provided by the
Cell Bank of the Sun Yat-sen University, were cut into
0.5- to 1-mm pieces and mixed in 5 mL RPMI 1640 (Life
Technologies, Carlsbad, CA, USA). One milliliter of the
VX2 solution (20%, approximately 1 × 1010 cells/mL)
and 0.2 mL of VX2 were injected into the quadriceps
femoris of one rabbit. After 21 days, a solid mass was re-
moved from the injection site, washed in normal saline,
and placed in RPMI 1640. Areas with active growth were
selected, and the tissue was cut into pieces of 0.5 to
1 mm in diameter. After vortexing, the solution (1 × 1010
cells/ml) was transferred to a syringe with a lumbar
puncture needle.
Establishment of an animal model of EC with RLN
metastasis
Animals in the experimental group were anesthetized with
3% pentobarbital sodium at 1 mL/kg via the ear vein and
then placed in a supine position. After sterilization, a mid-
line incision was made on the lower abdomen. After the
uterus was exposed, 0.5 mL of the VX2 solution was
injected into the muscularis mucosae of the myometrium
1 cm away from the cervix. The injection site was sutured,
and the wound was closed with a 1 to 0 suture.
Six animals in the normal control group were randomly
selected; they did not receive anesthesia or surgery. For
the saline group, six rabbits received an injection of
0.5 mL of normal saline into the muscularis mucosae of
the myometrium in place of the VX2 solution.
Sample collection and pathological examination
At 15, 18, 21, 24, 27, and 30 days post-injection of the
VX2 solution, rabbits were sacrificed by aeroembolism
(injection of air into the ear vein) (n = 6 per time point).
At 30 days, animals in the normal control and saline
groups were sacrificed by the same method. EC and
RLN tissues were observed macroscopically, and thelong diameter (a) and short diameter (b) were measured
to calculate EC and RLN volume using the following
equation: V = a × b2/2. Under aseptic conditions, the
uterus, EC, and RLNs were collected. The tissue was
fixed in 10% formalin and embedded in paraffin. Sec-
tions were obtained and stained with hematoxylin and
eosin (H&E). The stained EC and metastatic RLN tissues
were observed under a light microscope by two inde-
pendent pathologists.
Statistical analyses
Data are presented as means ± standard deviation (SD).
All statistical assessments were two-sided and evaluated
at the 0.05 level of significant difference. Statistical ana-
lyses were performed using SPSS 15.0 statistics software
(SPSS Inc, Chicago, IL, USA).
Results
Establishment of an animal model of EC with RLN
metastasis
All rabbits developed VX2 endometrial carcinoma which
were confirmed with pathological examination .As shown
in Figure 1, significantly increased tumor volume was ob-
served at days 24, 27, and 30 post-injection of VX2 cells
(P < 0.05). A representative image of the normal and
tumor endometrium after 21 days is shown in Figure 2A.
Histological analysis of the tumor tissue confirmed the
presence of tumor cells (Figure 2B).
The presence of RLN metastasis was also assessed.
RLN enlargement was not observed macroscopically at
15 days post-VX2 cell injection, and pathological exam-
ination confirmed the absence of RLN metastasis (data
not shown). However, at days 18 and 21 post-VX2 cell
injection, enlargement of several RLNs was observed






Figure 2 Macroscopic and pathological analysis of rabbit endometrium and RLNs. (A) EC at day 21. N, normal uterine body; T, endometrial
tumor. (B) Histological examination of the endometrium at day 21 revealed orthotopic EC (H&E, 200×). (C) Retroperitoneal lymph node metastasis
at day 21. E, enlarged RLN; N, normal RLN size. (D) Histological examination of RLN at day 21 revealed the presence of tumor cells (H&E, 400×).
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(data not shown). The presence of metastasis into
several RLNs was observed at 21 days post-injection
(Figure 2D). Enlargement of all RLNs and metastasis
was noted at days 24, 27, and 30 post-injection.Discussion
The VX2 cell line is composed of squamous cell carcin-
oma cells derived from Shope virus-induced papilloma
in rabbit [5]. Their high survival rates make them a suit-
able candidate for in vivo inoculation [5], which has
been carried out in the liver, lung, uterus, and breast tis-
sues to establish the corresponding animal models [6-8].
Domestic scholars confirmed by comparing different
means of transplantation that the successful rate of
tumor formation was high by tissue mass suspension in-
jection [9]. Due to small tissue blocks, the tumor cells
can obtain adequate nutrition and oxygen supply and
the concentration of tumor cells resists the barrier of
immunity, delaying the cleanup process, to ensure the
normal growth of the tumor cells. With high rate of
tumor formation and rapid growth, short modeling time
can be reduced. This experiment confirmed that modelof EC with RLN metastasis can be established within a
month.
In the endometrium, inoculation of VX2 cells induced
EC with lymph node metastasis after 14 to 21 days post-
injection [6,7], which is similar to the results of the
present study. These previous studies employed blocks
of VX2 cells in the myometrium using microsurgical in-
struments while the present study introduced the VX2
cells via an injection, which removes the dependence on
microsurgical instruments, that is less difficult and may
increase the success rate of establishing the model as
was evident in the 100% success rate of establishing EC
and RLN metastasis observed in this study. The high
success rate of this study using this method is consistent
with results reported by Chen et al. [8]. Use of VX2 cells
also induced EC more quickly than that reported for a
mouse model of EC with lymph node metastasis that re-
quired 8 weeks to establish [10].
Conclusions
Thus, an animal model of EC with RLN metastasis was
established. Experiments with the model, not only from
the biological level of endometrial cancer response but
also to various treatments, such as chemotherapy drug
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regimen, can also research the relationship between mo-
lecular markers from the molecular level with lymph
node metastasis and micrometastasis. The current hot
spot ‘molecular cancer staging,’ combining with the the-
ory and technology of molecular biology and clinical sta-
ging of tumor to diagnose micrometastasis lesions in the
body, which can make the stage of the tumor be deter-
mined more accurately, guides the determination of clin-
ical treatment programs and reduces recurrence and
distant metastasis. Therefore, this model provides a good
repeatability large animal model for experimental study
which is bound to have a major significance for the
study of endometrial tumors.
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